Pneumonia and Respiratory Infections
Pneumonia and Respiratory Infections is a research topic within Epidemiology. Science Explorer counts 45k research works in it since 1950. 10.0% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the management, epidemiology, and vaccination strategies for pneumonia, with a specific emphasis on community-acquired pneumonia and the role of Streptococcus pneumoniae. It covers topics such as the efficacy and safety of pneumococcal conjugate vaccines, burden of disease in children, antimicrobial resistance, and global estimates of morbidity and mortality due to lower respiratory infections.
- Pneumococcal Conjugate Vaccine
- Community-Acquired Pneumonia
- Streptococcus Pneumoniae
- Antimicrobial Resistance
- Childhood Pneumonia
- Invasive Pneumococcal Disease
- Clinical Practice Guidelines
- Vaccination
- Epidemiology
- Respiratory Infections
- Research works
- 45k fractional, since 1950
- In the world top 10%
- 4.5k per year above
- Top-10% rate
- 10.0% share of its works in the world top 10%
- Growth, 2018-21 → 2022-25
- +3% the tick is no change
- Largest producer
United States
28% of the 10 largest, 2022-now
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Pneumonia and Respiratory Infections research?
By volume, the United States and China publish the most (1.5k and 1.4k works in 2022-now).
By volume, 2022-now
- 1
United States 1.5k works
- 2
China 1.4k works
- 3
India 545 works
- 4
United Kingdom 361 works
- 5
Spain 329 works
- 6
Japan 287 works
- 7
France 262 works
- 8
Italy 235 works
- 9
Germany 193 works
- 10
Australia 184 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Pneumonia and Respiratory Infections research?
By volume in 2022-now, Pfizer (United States) publishes the most Pneumonia and Respiratory Infections research, followed by Capital Medical University and Instituto de Salud Carlos III.
By volume, 2022-now
- 1
Pfizer (United States)
United States 74 works
- 2
Capital Medical University
China 48 works
- 3
Instituto de Salud Carlos III
Spain 44 works
- 4
Merck & Co., Inc., Rahway, NJ, USA (United States)
United States 43 works
- 5
Harvard University
United States 41 works
- 6
United States Department of Health and Human Services
United States 38 works
- 7
Zhejiang University
China 36 works
- 8
Inserm
France 35 works
- 9
Johns Hopkins University
United States 32 works
- 10
Fudan University
China 31 works
Who are the leading researchers in Pneumonia and Respiratory Infections?
The most-cited researchers publishing on Pneumonia and Respiratory Infections include Christopher J L Murray, Simon Iain Hay and Theo Vos.
- 1
Christopher J L Murray
United States 583k citations
- 2
Simon Iain Hay
United States 452k citations
- 3
Theo Vos
United States 439k citations
- 4
Ali H. Mokdad
United States 429k citations
- 5
Walter Churchill Willett
United States 411k citations
- 6
Julian P. T. Higgins
United Kingdom 390k citations
- 7
Zulfiqar Ahmed Bhutta
Pakistan 371k citations
- 8
Shizuo Akira
Japan 342k citations
- 9
Jun Wang
China 340k citations
- 10
Matthias Egger
Switzerland 326k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Pneumonia and Respiratory Infections research done?
The largest centres of Pneumonia and Respiratory Infections research in 2022-now are Beijing (China), London (United Kingdom), Paris (France) and Madrid (Spain). Among places with at least 20 works in it, it is an unusually large share of all research in Rahway.
Largest cities, 2022-now
Where it is the local speciality
- RahwayUS · 33.0 works48×
Location quotient: how much more of its research is in Pneumonia and Respiratory Infections than the world average.
Where is the best place to study Pneumonia and Respiratory Infections?
Among universities, judged by research, Capital Medical University, Zhejiang University and University of Oxford score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.
Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.
Every institution in Pneumonia and Respiratory Infections, country by countryIs Pneumonia and Respiratory Infections research growing?
Output in 2022-2025 was 3% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Pneumonia and Respiratory Infections.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Pneumonia and Respiratory Infections as a percentage of every work published that year, 0.032% in 2024.
Fractional works of Pneumonia and Respiratory Infections over all fractional works that year. How the balance of science has shifted.
How much of it reaches the world top 10%
Year by year.
Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.
Discussion
Ask a question or share a note about Pneumonia and Respiratory Infections. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.